JT

John Tucker

Person

John Tucker is a journalist and broadcaster at Bloomberg, where he covers financial markets and corporate earnings. He frequently hosts and contributes to Bloomberg programs, providing analysis on major retail and industrial stocks.

What John Tucker has said on podcasts

16 statements

  1. on StubHub refund processNegativeAug 13, 2026· Stock Movers

    StubHub must fix its ticket-refund problems to address tangible consumer distrust.

    “The distrust in the system is tangible. They got to fix it.”

    Listen at 1:29

    Open the episode · StubHub and Cerebras Lower; Birkenstock Rallies
  2. on Tyson 2026 adjusted operating incomeNegativeAug 3, 2026· Stock Movers

    Tyson lowered its 2026 adjusted operating-income outlook to $2.1–$2.3 billion.

    “Annual adjusted operating income of 2.1 billion to 2.3 billion for 2026. So that's they've lowered the range there.”

    Listen at 1:01

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  3. on Tyson production-capacity reductionsNegativeAug 3, 2026· Stock Movers

    Tyson’s production-capacity reductions have not yet significantly affected results.

    “This weaker outlook suggests Tyson's efforts to reduce production capacity. They've yet to really have any significant impact.”

    Listen at 1:10

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  4. on Tyson 2026 adjusted operating lossNegativeAug 3, 2026· Stock Movers

    Tyson is expected to report a $500–$650 million adjusted operating loss for 2026.

    “Tyson is now expected to post an adjusted operating loss of 500 million to $650 million for the year, deeper than some of the prior expectations.”

    Listen at 1:49

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  5. on AstraZeneca–Bristol Myers Squibb combinationPositiveAug 3, 2026· Stock Movers

    Combining AstraZeneca and Bristol Myers Squibb would create the world’s largest drug maker.

    “It would form the world's biggest drug maker with about $107 billion in annual revenue.”

    Listen at 2:34

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  6. on Bristol Myers Squibb acquisition by AstraZenecaPositiveAug 3, 2026· Stock Movers

    Bristol Myers Squibb could give AstraZeneca a larger U.S. market foothold.

    “Bristol Myers Squibb could provide Astra with a bigger foothold in the US Market.”

    Listen at 2:42

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  7. on SpaceX earnings call commentaryNeutralAug 3, 2026· Stock Movers

    Elon Musk’s commentary will matter more than SpaceX’s financial results.

    “I don't think the financials are going tomorrow are going to matter as much as the commentary from from Elon during the call.”

    Listen at 3:54

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  8. on SpaceX governance and investment riskNegativeAug 3, 2026· Stock Movers

    Institutional investors consider SpaceX risky because of Elon Musk’s unprecedented control.

    “a lot of institutional investors, they, they were sour on this to begin with because in part because of the unprecedented control that Elon Musk has over SpaceX, they consider it a little too risky to hold.”

    Listen at 4:14

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  9. on Elon Musk SpaceX voting rightsNegativeAug 3, 2026· Stock Movers

    Elon Musk holds more than 80% of SpaceX’s voting rights.

    “MUST sits on over 80% of the voting rights.”

    Listen at 4:28

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  10. on SpaceX lockup expirationNegativeAug 3, 2026· Stock Movers

    SpaceX’s lockup expiration will release 911 million shares after earnings.

    “Just a few days after earnings, the lockup ends. So regardless of how good or bad the results are, 911 million shares are subject to the lockup will be released.”

    Listen at 4:43

    Open the episode · Bristol-Myers Squibb Potential Merger; SpaceX to Report; Tyson Drops
  11. on United Airlines trading revenuesPositiveJul 12, 2026· Stock Movers

    United Airlines trading revenues should remain historically elevated.

    “trading revenues should remain historically elevated”

    Listen at 2:10

    Open the episode · Week Ahead: JPMorgan Chase, United Airlines, Netflix
  12. on Investment bankingPositiveJul 12, 2026· Stock Movers

    Investment banking is expected to remain resilient despite market volatility.

    “the investment banking looks to stay resilient despite what we'll call market volatility.”

    Listen at 2:13

    Open the episode · Week Ahead: JPMorgan Chase, United Airlines, Netflix
  13. on SB NeoPositiveJul 2, 2026· Stock Movers

    SB Neo will offer cloud computing services to major US enterprises from March 2028.

    “The new company is going to be called SB Neo. It aims to offer cloud computing services to major US enterprises, including the hyperscalers. Starting in March of 2028.”

    Listen at 2:20

    Open the episode · SoftBank Venture and Google Legal Fight
  14. on SB NeoNeutralJul 2, 2026· Stock Movers

    SB Neo will compete with CoreWeave in the cloud services market.

    “They'll compete with the likes of Core, Weave, Softbank joining a crowded cloud services field”

    Listen at 2:34

    Open the episode · SoftBank Venture and Google Legal Fight
  15. on Meta AI computing power salesNegativeJul 2, 2026· Stock Movers

    Meta’s potential AI-computing access sales are weighing on memory-chip stocks.

    “word that Meta platforms working on selling access to its AI computing power that's weighing on memory chip stocks like M.”

    Listen at 2:47

    Open the episode · SoftBank Venture and Google Legal Fight
  16. on MetaNegativeJul 2, 2026· Stock Movers

    Analysts say Meta could severely damage the Neo cloud business.

    “Analysts say Meta could crash the Neo cloud.”

    Listen at 2:54

    Open the episode · SoftBank Venture and Google Legal Fight

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

2 episodes featuring John Tucker

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

John Tucker | PodLume